我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

抽象的

Neglected Factor during Cancer Progression by Hyperglycemia

Laura Soysal

Recent data from sizable cohort studies shows that persons with type 2 diabetes have a greater cancer incidence. The probable causes of this relationship are yet unknown, though, as of this writing. These glucosehungry cells may get extra glucose from hyperglycemia, the most significant aspect of diabetes, which also leads to oncogenesis, apoptosis resistance, and chemotherapy-resistant tumour cells [1]. The impact of hyperglycemia on the advancement of cancer in cancer patients with abnormal blood glucose levels should not be disregarded given the link between diabetes and malignancies [2]. In this article, we discuss the role that hyperglycemia plays in the development of cancer and its management, as well as how it might influence the phenotypic of cancer cells and promote drug resistance. Consequently, managing hyperglycemia may Hyperglycemia, also known as high blood glucose, is a condition that occurs when there is either an insufficient quantity of insulin in the body or when the body is unable to properly utilise the insulin that is present [3].